Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HDAC10 is a class IIb histone deacetylase primarily functioning as a polyamine deacetylase, selectively deacetylating long-chain polyamines such as N8-acetylspermidine. It plays roles in epigenetic regulation, autophagy, and cell cycle control. HDAC10 is a potential therapeutic target in cancer due to its involvement in tumor growth regulation and autophagy modulation, with both oncogenic and tumor-suppressive roles depending on cellular context.
Inhibition of HDAC10 enzymatic activity, leading to increased acetylation of target proteins (polyamines and potentially histones) and modulation of downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyamine deacetylase HDAC10 (HDAC10).